Latest Regulatory News

Tamboran Resources Corporation is extending its capital raise with a partially underwritten retail entitlement offer worth up to A$27 million, following a US$163 million institutional and public offering. The proceeds will accelerate drilling and resource delineation in the Beetaloo Basin, aiming to underpin first gas sales in 2026.

European Resources Limited (ASX: ERE) has repriced and relaunched a renounceable rights issue to raise up to $3.4 million, partially underwritten by Mahe Capital for $1.5 million, to fund metallurgical and exploration work at its Korsnäs rare earth project in Finland and Slovakian tenements.

Insignia Financial shareholders met on 13 April 2026 and overwhelmingly backed a $4.80 per share acquisition scheme by CC Capital, valuing the company at about $3.3 billion and offering a near 57% premium to pre-offer prices.

Solstice Minerals has successfully closed a $32.6 million placement and raised an additional $0.81 million through option exercises, issuing nearly 35 million new shares now available for immediate trading.

Eclipse Metals’ 2025 drilling at Grønnedal reveals broad rare earth mineralisation from surface, with multiple zones exceeding 1% TREO and a strong Nd-Pr magnet rare earth profile, reinforcing the project’s strategic importance.

Element 25 has secured $18 million through a share placement to fund the expansion of its Butcherbird Manganese Project, aiming to increase output to 1.1 million tonnes annually and support its US battery-grade manganese facility.

Jameson Resources has secured A$3 million through a discounted share placement to advance critical environmental approvals and Indigenous engagement for its Crown Mountain coal project in British Columbia, aiming to submit the final application by late 2026.

Southern Cross Gold Consolidated Ltd. has transitioned its Sunday Creek project into execution, commencing surface works and targeting a maiden inferred resource in early 2027, supported by a robust $123.2 million cash position.

EMVision Medical Devices has ramped up recruitment in its pivotal FDA trial across eight hospitals and is nearing results from multiple pre-hospital studies, all while bolstering its cash position with a $3.8 million R&D tax refund and $6.6 million in grant funding.

Rimfire Pacific Mining has boosted its Murga Scandium Deposit resource by 300%, lifting the inferred mineral resource to 56.1 million tonnes at 138ppm scandium. The deposit’s low iron content hints at potential cost savings via atmospheric leaching, with follow-up drilling and metallurgical tests slated for mid-2026.

Argent BioPharma has finalized the acquisition of CannPal Animal Therapeutics, securing a Phase 3 veterinary epilepsy asset with near-term commercial prospects and an option to acquire the Neuvis® drug delivery platform, enhancing its neurological portfolio and U.S. market ambitions.

Diatreme Resources is consolidating its Far North Queensland silica assets by selling the Cape Flattery Silica Project to its joint venture with Sibelco, securing $7.4 million in fresh capital and streamlining project ownership ahead of key development milestones.